期刊文献+

CD47分子胞外区蛋白单克隆抗体的制备与鉴定 被引量:1

Preparement and identification of monoclonal antibody against extracellular region of human CD47 protein
下载PDF
导出
摘要 目的制备和鉴定抗人CD47分子胞外区蛋白单克隆抗体。方法聚合酶链反应扩增人CD47胞外区基因序列,重组至原核表达载体pET-32a(+)中,利用大肠埃希菌表达系统表达CD47胞外区蛋白。用纯化的CD47胞外区蛋白免疫小鼠,采用常规方法进行细胞融合,经克隆化培养后,筛选能够特异性分泌鼠抗人CD47单克隆抗体的杂交瘤细胞株。采用酶联免疫吸附法、Western blot和流式技术检测抗体效价及特异性。结果成功构建人CD47原核表达载体,在BL21(DE3)中获得表达,经十二烷基磺酸钠-聚丙烯酰胺凝胶电泳、Western blot鉴定后,采用层析柱法获得纯化的CD47胞外区蛋白。以纯化蛋白为免疫原,成功制备具有较强亲和力的单克隆抗体。结论成功制备了针对CD47分子胞外区蛋白的高亲和力单克隆抗体,为进一步研究CD47的生物学功能奠定了基础。 Objective To prepare and identify anti-CD47 monoclonal antibodies.Methods The gene fragment of CD47 was amplified by polymerase chain reaction and cloned into prokaryotic expressing vector pET-32a(+).Purified reconstructed protein was used to immunize BALB/c mice.The immunized spleen cells were isolated and fused with Sp2/0cells.After screened,hybridomas secreting anti-CD47 monoclonal antibody were acquired.Biological activities of antibodies were investigated by Western blot and flow cytometry.Results The recombinant CD47 extracellular domain protein was successfully expressed in BL21,and certificated by sodium dodecyl sulfate polyacrylamide gel electropheresis and Western blot.Data of flow cytometry detection demonstrated that the antiserum had high affinity to CD47 protein.Conclusion Recombinant CD47 and its monoclonal antibody,with high affinity,were successfully prepared,which could provide reliable tools for the future study of CD47.
出处 《国际检验医学杂志》 CAS 2015年第21期3125-3127,共3页 International Journal of Laboratory Medicine
关键词 CD47 基因表达 单克隆抗体 CD47 gene expression monoclonal antibody
  • 相关文献

参考文献11

  • 1Matozaki T, Murata Y, Okazawa H, et al. Functions and molecular mechanisms of the CD47 SIRP alpha signaling pathway [J]. Trends Cell Biol,2009,19(2) : 72-80. 被引量:1
  • 2Chao MP,Alizadeh AA,Tang C,et al. Anti-CD47 antibody syner- gizes with rituximab to promote phagocytosis and eradicate non- Hodgkin lymphoma[J]. Cell, 2010,142(5) : 699-713. 被引量:1
  • 3Nagahara M, Mimori K, Kataoka A, et al. Correlated expression of CD47 and SIRPA in bone marrow and in peripheral blood predicts recurrence in breast cancer patients[J]. Clin Cancer Res, 2010,16 (18) :4625-4635. 被引量:1
  • 4Chao MP,Alizadeh AA,Tang C,et al. Anti-CD47 antibody syner- gizes with rituximab to promote phagoeytosis and eradicate non- Hodgkin lymphoma[J]. Cell, 2010,142 (5) : 699-713. 被引量:1
  • 5Willingham SB, Volkmer JP, Gentles AJ, et al. The CD47-signal regulatory protein alpha(SIRPa)interaetion is a therapeutic target for human solid tumors[J]. PNAS,2012,109(17) :6662-6667. 被引量:1
  • 6鞠宝辉,黄宇婷,田菁,冯慧,胡林萍,袁卫平,郝权.抗CD47单克隆抗体对卵巢癌细胞靶向治疗的体外研究[J].中国肿瘤临床,2013,40(8):440-443. 被引量:5
  • 7Kim D, Wang J, Willingham SB, et al. Anti-CD47 antibodies pro- mote phagocytosis and inhibit the growth of human myeloma cells [J]. Leukemia,2012,26(12) :2538 -2545. 被引量:1
  • 8Chao MP, Alizadeh AA, Tang C, et al. Therapeutic antibody tar- geting of CD47 eliminates human acute lymphoblastic leukemia [J]. Cancer Res,2011,71(4) :1374 -1384. 被引量:1
  • 9Chao MP, Weissman IL, Majeti R. The CD47-SIRPalpha pathway in cancer immune evasion and potential therapeutic implications [J]. Curr Opin Immunol,2012,24(2) :225-232. 被引量:1
  • 10杨梅,吴敬波,张智慧.CD47与淋巴瘤相关性的研究进展[J].肿瘤预防与治疗,2014,27(6):285-288. 被引量:3

二级参考文献70

  • 1尹美珍,李世普,袁琳,戴红莲.小鼠腹腔巨噬细胞的分离培养与鉴定[J].武汉大学学报(医学版),2006,27(2):203-205. 被引量:36
  • 2Kobayashi E, Veda Y, Matsuzaki S, et al. Biomarkers for screening, diagnosis, and monitoring of ovarian cancer[J], Cancer Epidemiol Biomarkers Prev, 2012, 21(11):1902-1912. 被引量:1
  • 3Chan A, Gilks B, KwonJ, et al. New insights into the pathogenesis of ovarian carcinoma: time to rethink ovarian cancer screening[J]. Obstet Gynecol, 2012,120(4):935-940. 被引量:1
  • 4Matozaki T, Murata Y, Okazawa H, et al. Functions and molecular mechanisms of the CD47-SIRPalpha signalling pathway[J]. Trends Cell Bioi, 2009, 19(2):72-80. 被引量:1
  • 5Zhao XW, van Beek EM, Schornagel K, et al. CD47-signal regula?tory protein-alpha (SIRPalpha) interactions form a barrier for anti?body-mediated tumor cell destruction[J]. Proc Natl Acad Sci V S A, 2011,108(45):18342-18347. 被引量:1
  • 6Olsson M, Nilsson A, Oldenborg PA. Target cell CD47 regulates macrophage activation and erythrophagocytosis[J], Transfus Clin Biol,2006,13(1-2):39-43. 被引量:1
  • 7Campbell IG, Freemont PS, Foulkes W, et al. An ovarian tumor marker with homology to vaccinia virus contains an IgV-like re?gion and multiple transmembrane domains[J]. Cancer Res, 1992,52 (19) :5416-5420. 被引量:1
  • 8Majeti R, Chao MP, Alizadeh AA, et al. CD47 is an adverse prog? nostic factor and therapeutic antibody target on human acute my?eloid leukemia stem cells[J]. Cell, 2009,138(2):286-299. 被引量:1
  • 9Chan KS, Espinosa I, Chao M, et al. Identification, molecular char?acterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cellsm. Proc Nat! Acad Sci V S A, 2009, 106(33) :14016-1402l. 被引量:1
  • 10Nagahara M, Mimori K, Kataoka A, et al. Correlated expression of CD47 and SIRPA in bone marrow and in peripheral blood predicts recurrence in breast cancer patients[J]. Clin Cancer Res, 2010, 16 (18) :4625-4635. 被引量:1

共引文献16

同被引文献11

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部